Anti-CD3:anti-IL-2 receptor-bispecific mAb-mediated immunomodulation. Low systemic toxicity, differential effect on lymphoid tissue, and inhibition of cell-mediated hypersensitivity
(Q71746782)
scientific article published on 01 October 1995
scientific article published on 01 October 1995
Language: